Fifth Third Bancorp’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $85.7M | Sell |
158,184
-6,794
| -4% | -$3.83M | 0.14% | 136 |
|
|
2026
Q1 | $97.8M | Buy |
164,978
+164,519
| +35,843% | +$81.9M | 0.18% | 112 |
|
|
2025
Q4 | $224K | Hold |
459
| – | – | ﹤0.01% | 954 |
|
|
2025
Q3 | $192K | Buy |
459
+16
| +4% | +$5.38K | ﹤0.01% | 1033 |
|
|
2025
Q2 | $127K | Sell |
443
-44
| -9% | -$13.2K | ﹤0.01% | 1077 |
|
|
2025
Q1 | $150K | Buy |
487
+90
| +23% | +$30.8K | ﹤0.01% | 1026 |
|
|
2024
Q4 | $140K | Sell |
397
-38
| -9% | -$14K | ﹤0.01% | 1047 |
|
|
2024
Q3 | $156K | Sell |
435
-150
| -26% | -$50.7K | ﹤0.01% | 1050 |
|
|
2024
Q2 | $186K | Buy |
585
+68
| +13% | +$18K | ﹤0.01% | 990 |
|
|
2024
Q1 | $119K | Sell |
517
-1,126
| -69% | -$254K | ﹤0.01% | 1088 |
|
|
2023
Q4 | $361K | Sell |
1,643
-160
| -9% | -$36.9K | ﹤0.01% | 835 |
|
|
2023
Q3 | $407K | Buy |
1,803
+175
| +11% | +$40.3K | ﹤0.01% | 796 |
|
|
2023
Q2 | $359K | Sell |
1,628
-48
| -3% | -$10.6K | ﹤0.01% | 821 |
|
|
2023
Q1 | $375K | Sell |
1,676
-553
| -25% | -$136K | ﹤0.01% | 821 |
|
|
2022
Q4 | $620K | Sell |
2,229
-270
| -11% | -$68.2K | ﹤0.01% | 651 |
|
|
2022
Q3 | $523K | Buy |
2,499
+73
| +3% | +$16.3K | ﹤0.01% | 673 |
|
|
2022
Q2 | $572K | Buy |
2,426
+53
| +2% | +$10.8K | ﹤0.01% | 651 |
|
|
2022
Q1 | $426K | Buy |
2,373
+174
| +8% | +$33.1K | ﹤0.01% | 771 |
|
|
2021
Q4 | $475K | Buy |
2,199
+194
| +10% | +$38.1K | ﹤0.01% | 736 |
|
|
2021
Q3 | $370K | Buy |
2,005
+1,861
| +1,292% | +$367K | ﹤0.01% | 787 |
|
|
2021
Q2 | $26K | Hold |
144
| – | – | ﹤0.01% | 1711 |
|
|
2021
Q1 | $24K | Buy |
144
+45
| +45% | +$7.5K | ﹤0.01% | 1710 |
|
|
2020
Q4 | $15K | Buy |
99
+80
| +421% | +$10.5K | ﹤0.01% | 1803 |
|
|
2020
Q3 | $2K | Buy |
+19
| New | +$2.08K | ﹤0.01% | 2087 |
|
|
2019
Q3 | – | Sell |
-28
| Closed | -$2K | – | 2356 |
|
|
2019
Q2 | $2K | Buy |
+28
| New | +$2.62K | ﹤0.01% | 2160 |
|
|
2019
Q1 | – | Sell |
-2
| Closed | – | – | 2310 |
|
|
2018
Q4 | $0 | Buy |
+2
| New | +$232 | ﹤0.01% | 2347 |
|
|
2016
Q1 | – | Sell |
-128
| Closed | -$20K | – | 2682 |
|
|
2015
Q4 | $20K | Sell |
128
-26
| -17% | -$3.79K | ﹤0.01% | 1690 |
|
|
2015
Q3 | $20K | Buy |
154
+47
| +44% | +$7.54K | ﹤0.01% | 1737 |
|
|
2015
Q2 | $19K | Buy |
107
+24
| +29% | +$4.32K | ﹤0.01% | 1837 |
|
|
2015
Q1 | $14K | Buy |
+83
| New | +$12.7K | ﹤0.01% | 1877 |
|
|
2014
Q4 | – | Sell |
-67
| Closed | -$9K | – | 2481 |
|
|
2014
Q3 | $9K | Hold |
67
| – | – | ﹤0.01% | 2034 |
|
|
2014
Q2 | $6K | Sell |
67
-8
| -11% | -$769 | ﹤0.01% | 2147 |
|
|
2014
Q1 | $7K | Buy |
+75
| New | +$7.67K | ﹤0.01% | 2071 |
|
|
2013
Q4 | – | Sell |
-30
| Closed | -$2K | – | 2240 |
|
|
2013
Q3 | $2K | Sell |
30
-159
| -84% | -$11.6K | ﹤0.01% | 2131 |
|
|
2013
Q2 | $12K | Buy |
+189
| New | +$12.2K | ﹤0.01% | 1748 |
|
Other funds holding UTHR
ACA
JT
Fifth Third Bancorp's UTHR Position: Q2 2026 in Review
Fifth Third Bancorp reduced its United Therapeutics (UTHR) stake by 4.1% in Q2 2026, selling an estimated $3.83M and leaving 158,184 shares worth $85.7M. The position accounts for 0.14% of the portfolio, ranked #136.
Fifth Third Bancorp first reported a position in UTHR in Q2 2013 and has held it in 35 quarters since. The position peaked at $97.8M in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Fifth Third Bancorp held 158,184 shares of United Therapeutics worth $85.7M as of Q2 2026.
- Fifth Third Bancorp sold 6,794 United Therapeutics shares in Q2 2026, an estimated $3.83M.
- United Therapeutics made up 0.14% of Fifth Third Bancorp's portfolio in Q2 2026, its #136 holding.
- Fifth Third Bancorp first reported a position in United Therapeutics in Q2 2013 and has held it in 35 quarters since.
- Fifth Third Bancorp's United Therapeutics position peaked at $97.8M in Q1 2026.
- 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.